{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:51:27Z","timestamp":1792446687170,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ajog.2020.08.045","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T10:53:46Z","timestamp":1598007226000},"page":"S1108-S1119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":314,"special_numbering":"S","title":["Prevention of preeclampsia with aspirin"],"prefix":"10.1016","volume":"226","author":[{"given":"Daniel L.","family":"Rolnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kypros H.","family":"Nicolaides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liona C.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2020.08.045_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2020.08.045_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajog.2017.04.032","article-title":"Short-term costs of preeclampsia to the United States health care system","volume":"217","author":"Stevens","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib3","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/S0140-6736(00)02384-9","article-title":"Adult cardiovascular risk factors in premature babies","volume":"355","author":"Irving","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.08.045_bib4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1056\/NEJMoa0706475","article-title":"Long-term medical and social consequences of preterm birth","volume":"359","author":"Moster","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.08.045_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003497","article-title":"Preeclampsia and future cardiovascular health: a systematic review and meta-analysis","volume":"10","author":"Wu","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ajog.2020.08.045_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/uog.17534","article-title":"Decreased endothelial function and increased subclinical heart failure in women several years after pre-eclampsia","volume":"52","author":"Breetveld","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib7","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/HYPERTENSIONAHA.109.130765","article-title":"Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother","volume":"53","author":"Lykke","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.08.045_bib8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/ajo.12499","article-title":"Management of pregnancies complicated by hypertensive disorders of pregnancy: could we do better?","volume":"57","author":"Helou","year":"2017","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jogc.2017.04.040","article-title":"Low rates of aspirin use for the prevention of preeclampsia","volume":"39","author":"Viguiliouk","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2020.08.045_bib11","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O\u2019Gorman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib13","doi-asserted-by":"crossref","first-page":"650.e1","DOI":"10.1016\/j.ajog.2019.09.041","article-title":"Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population","volume":"221","author":"Chaemsaithong","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/uog.17399","article-title":"Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib15","doi-asserted-by":"crossref","first-page":"f6564","DOI":"10.1136\/bmj.f6564","article-title":"Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis","volume":"347","author":"Ananth","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.08.045_bib16","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.08.045_bib17","first-page":"619","article-title":"CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.08.045_bib18","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.08.045_bib19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0002-9610(49)90394-3","article-title":"The Ebers papyrus","volume":"77","author":"Cunha","year":"1949","journal-title":"Am J Surg"},{"key":"10.1016\/j.ajog.2020.08.045_bib20","first-page":"179","article-title":"The discovery of aspirin\u2019s antithrombotic effects","volume":"34","author":"Miner","year":"2007","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.ajog.2020.08.045_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2018.10.008","article-title":"The first 3500 years of aspirin history from its roots - a concise summary","volume":"113","author":"Montinari","year":"2019","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.ajog.2020.08.045_bib22","first-page":"713","article-title":"[Aspirin in the treatment of myocardial infarct]","volume":"52","author":"Huttman","year":"1971","journal-title":"G\u00a0Clin Med"},{"key":"10.1016\/j.ajog.2020.08.045_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1378\/chest.45.6.572","article-title":"Anticoagulant drug therapy in acute cornonary thrombosis and allied conditions","volume":"45","author":"Master","year":"1964","journal-title":"Dis Chest"},{"key":"10.1016\/j.ajog.2020.08.045_bib24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1016\/j.ajog.2020.08.045_bib25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"Vane","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2020.08.045_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jmgm.2012.12.013","article-title":"Mechanism of the irreversible inhibition of human cyclooxygenase-1 by aspirin as predicted by QM\/MM calculations","volume":"40","author":"T\u00f3th","year":"2013","journal-title":"J\u00a0Mol Graph Model"},{"key":"10.1016\/j.ajog.2020.08.045_bib27","doi-asserted-by":"crossref","first-page":"l2381","DOI":"10.1136\/bmj.l2381","article-title":"Pre-eclampsia: pathophysiology and clinical implications","volume":"366","author":"Burton","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.08.045_bib28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0002-9378(97)70516-7","article-title":"Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules","volume":"176","author":"Konijnenberg","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib29","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/1471-0528.13914","article-title":"Low dose aspirin and pregnancy: how important is aspirin resistance?","volume":"123","author":"Navaratnam","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.08.045_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(78)91367-3","article-title":"Aspirin for the treatment of recurrent toxaemia","volume":"2","author":"Goodlin","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.08.045_bib31","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0140-6736(85)92207-X","article-title":"Prevention of pre-eclampsia by early antiplatelet therapy","volume":"1","author":"Beaufils","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.08.045_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2020.08.045_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib35","first-page":"e1","article-title":"SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014","volume":"55","author":"Lowe","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib36","article-title":"Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE)","volume":"6","author":"O\u2019Gorman","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2020.08.045_bib37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/07420528.2012.717455","article-title":"Chronotherapy with low-dose aspirin for prevention of complications in pregnancy","volume":"30","author":"Ayala","year":"2013","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ajog.2020.08.045_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2020.08.045_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000338470","article-title":"A\u00a0competing risks model in early screening for preeclampsia","volume":"32","author":"Wright","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2020.08.045_bib40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.08.045_bib41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib42","doi-asserted-by":"crossref","first-page":"585.e1","DOI":"10.1016\/j.ajog.2017.07.038","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history","volume":"217","author":"Poon","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib43","doi-asserted-by":"crossref","first-page":"685.e1","DOI":"10.1016\/j.ajog.2017.08.110","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia","volume":"217","author":"Wright","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib44","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)93025-7","article-title":"Aspirin and congenital malformations","volume":"1","author":"Slone","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.08.045_bib45","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.ajog.2004.10.598","article-title":"Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study","volume":"192","author":"N\u00f8rg\u00e5rd","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib46","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0002-9378(94)70056-7","article-title":"Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy","volume":"171","author":"Di Sessa","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-2005-864116","article-title":"Prenatal constriction of the fetal ductus arteriosus\u2013related to maternal pain medication?","volume":"209","author":"Schiessl","year":"2005","journal-title":"Z\u00a0Geburtshilfe Neonatol"},{"key":"10.1016\/j.ajog.2020.08.045_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ije\/dyx235","article-title":"Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child","volume":"47","author":"Petersen","year":"2018","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ajog.2020.08.045_bib49","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1471-0528.1995.tb10872.x","article-title":"Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. CLASP collaborative group","volume":"102","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022056","article-title":"Trial of feasibility and acceptability of routine low-dose aspirin versus Early Screening Test indicated aspirin for pre-eclampsia prevention (TEST study): a multicentre randomised controlled trial","volume":"8","author":"Mone","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2020.08.045_bib51","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 1)","volume":"110","author":"Subtil","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.08.045_bib52","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"329","author":"Sibai","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.08.045_bib53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ajog.2017.12.238","article-title":"Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib54","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1016\/j.ajpath.2016.08.010","article-title":"Low-dose acetylsalicylic acid treatment modulates the production of cytokines and improves trophoblast function in an in\u00a0vitro model of early-onset preeclampsia","volume":"186","author":"Panagodage","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajog.2020.08.045_bib55","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.placenta.2015.01.004","article-title":"Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1","volume":"36","author":"Li","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.08.045_bib56","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1097\/HJH.0000000000002185","article-title":"Aspirin enhances trophoblast invasion and represses soluble fms-like tyrosine kinase 1 production: a putative mechanism for preventing preeclampsia","volume":"37","author":"Su","year":"2019","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ajog.2020.08.045_bib57","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2019.02.034","article-title":"Aspirin delays the development of preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib58","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/uog.20411","article-title":"Revised competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal characteristics and medical history","volume":"54","author":"Benk\u0151","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib59","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0002-9378(00)70350-4","article-title":"Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"182","author":"Sibai","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib60","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/uog.17470","article-title":"Hidden high rate of pre-eclampsia in twin compared with singleton pregnancy","volume":"50","author":"Francisco","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib61","doi-asserted-by":"crossref","first-page":"428.e1","DOI":"10.1016\/j.ajog.2007.10.783","article-title":"Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?","volume":"198","author":"Bdolah","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib62","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/uog.17531","article-title":"Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks\u2019 gestation","volume":"50","author":"Francisco","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib63","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"743: low-dose aspirin use during pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib64","doi-asserted-by":"crossref","first-page":"l5119","DOI":"10.1136\/bmj.l5119","article-title":"Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance","volume":"366","author":"Webster","year":"2019","journal-title":"BMJ"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2020.08.045_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2020.08.045_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.03.005","article-title":"The role of aspirin in prevention of preeclampsia in twin pregnancies: does the dose matter?","author":"Kalafat","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib67","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/uog.18072","article-title":"P08.03: Low-dose aspirin for prevention of fetal growth restriction and pre-eclampsia in twins: the GAP pilot randomised trial","volume":"50","author":"Carpentier","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib68","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-0035-1570381","article-title":"Prevention of preeclampsia with aspirin in multiple gestations: a systematic review and meta-analysis","volume":"33","author":"Bergeron","year":"2016","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2020.08.045_bib69","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib70","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/uog.19077","article-title":"Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE","volume":"52","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib71","doi-asserted-by":"crossref","first-page":"612.e1","DOI":"10.1016\/j.ajog.2018.02.014","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit","volume":"218","author":"Wright","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib72","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1055\/s-0035-1570379","article-title":"Role of the placenta in preterm birth: a review","volume":"33","author":"Morgan","year":"2016","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2020.08.045_bib73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.08.045_bib74","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.08.045_bib75","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jacc.2011.02.005","article-title":"Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association","volume":"57","author":"Mosca","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ajog.2020.08.045_bib76","doi-asserted-by":"crossref","first-page":"e843","DOI":"10.1161\/CIR.0000000000000582","volume":"137","author":"Brown","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.08.045_bib77","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/1471-0528.16193","article-title":"Maternal cardiac function in women at high risk for pre-eclampsia treated with 150 mg aspirin or placebo: an observational study","volume":"127","author":"Ling","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.08.045_bib78","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/HYPERTENSIONAHA.118.11191","article-title":"Cardiovascular system in preeclampsia and beyond","volume":"73","author":"Thilaganathan","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.08.045_bib79","doi-asserted-by":"crossref","first-page":"141.e1","DOI":"10.1016\/j.ajog.2016.09.086","article-title":"Should we recommend universal aspirin for all pregnant women?","volume":"216","author":"Mone","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib80","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/AOG.0000000000001115","article-title":"A\u00a0cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States","volume":"126","author":"Werner","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib81","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0000000000003413","article-title":"Strategies for prescribing aspirin to prevent preeclampsia: a cost-effectiveness analysis","volume":"134","author":"Mallampati","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib82","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/HYPERTENSIONAHA.118.11718","article-title":"Preeclampsia prevention using routine versus screening test-indicated aspirin in low-risk women","volume":"72","author":"Mone","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.08.045_bib83","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/AOG.0000000000003631","article-title":"Strategies for prescribing aspirin to prevent preeclampsia: a cost-effectiveness analysis","volume":"135","author":"Cuckle","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib84","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1471-0528.1998.tb10088.x","article-title":"Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications","volume":"105","author":"Rotchell","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2020.08.045_bib85","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.08.045_bib86","series-title":"Costs of gestational hypertensive disorders in California: hypertension, preeclampsia, and eclampsia","author":"Pourat","year":"2013"},{"key":"10.1016\/j.ajog.2020.08.045_bib87","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pd.2871","article-title":"Economic assessment of screening for pre-eclampsia","volume":"32","author":"Shmueli","year":"2012","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2020.08.045_bib88","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"Lefevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2020.08.045_bib89","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/uog.19076","article-title":"Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia","volume":"53","author":"Ortved","year":"2019","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820308735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820308735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:38:38Z","timestamp":1757590718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937820308735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0002937820308735"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2020.08.045","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of preeclampsia with aspirin","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2020.08.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}